by Kristen Monaco, July 3, 2024
Psilocybin mushrooms were the psychedelic substance most often used in the U.S. in 2023, according to a new RAND report.
New-onset anxiety doubled the risk of developing Parkinson’s disease among people 50 and up, according to a retrospective study. (British Journal of General Practice)
Most Americans did not know that primary care physicians could prescribe medications for opioid use disorder (OUD), survey data showed. (JAMA Network Open)
Here’s what some psychiatric drug developers said after an FDA advisory committee recommended against approving Lykos’ MDMA-assisted therapy for post-traumatic stress disorder. (BioSpace)
“Intelligent onesies” may offer a novel way of screening for autism and attention deficit-hyperactivity disorder. (Newsweek)
Cognitive behavioral therapy for psychosis, virtual reality intervention, integrated intervention, and music therapy were more efficacious than standard care in reducing symptoms of treatment-resistant schizophrenia, a network meta-analysis found. (Lancet Psychiatry)
Some experts are concerned that America has a drinking problem. (STAT)
Pregnant and postpartum women who died by suicide were more likely to have intimate partner problems, a recent argument, depressed mood, substance abuse or other abuse, physical health problems, or recent bereavement, compared with nonperinatal decedents. (JAMA Network Open)
A randomized trial found a web-based cognitive behavioral self-help intervention decreased symptoms and illness-related burden in people with bulimia. (JAMA Network Open)
A military lab found patterns of brain damage in Navy SEALS who died of suicide, but kept leaders in the dark. (New York Times)
Six categories of environmental toxicants were tied with depressive symptoms driven by systemic inflammation. (JAMA Network Open)
A large U.K. Biobank study identified suicide risk factors to help improve prevention. (Nature Human Behavior)
Teens with low cognitive function had a 2.68-fold higher risk for early-onset stroke than those with high cognitive function. (Journal of Epidemiology & Community Health)
Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2005–2024 MedPage Today, LLC, a Ziff Davis company. All rights reserved.
MedPage Today is among the federally registered trademarks of MedPage Today, LLC and may not be used by third parties without explicit permission.
Psilocybin Top Psychedelic; OUD Meds From PCPs; Trial Shows Promise for Bulimia – Medpage Today
